Devices › Device types
FDA product code FJI · class 2 · Gastroenterology, Urology
Dialyzer, capillary, hollow fiber: medical device reports filed with FDA
8,433 reports carry this product code, 1992–2026; 23 brands with a page.
- 8,433
- reports with this product code
- 0% of all MAUDE reports
- 138
- reports, 12 months to August 2026
- 141 in the 12 months before
- 55.2%
- classified as malfunction
- 62.3% across all reports
- 1.9%
- classified as death, as reported
- 0.9% across all reports
Product code FJI is FDA's classification for "Dialyzer, capillary, hollow fiber" (gastroenterology, Urology panel), a class 2 device. 8,433 medical device reports carry this product code, 0% of the MAUDE database, from January 1992 to August 2026.
138 reports arrived in the 12 months to August 2026, close to the 141 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (55.2%), injury (37.6%) and other (4.4%). 23 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Optiflux 180nre Dialyzer Finished Assy | 1,226 | 69 | 0.6% | 85.3% |
| Ct Gamma Dialyzer Ct 190g | 1,011 | 0 | 0.3% | 94.9% |
| Optiflux 160nre Dialyzer Finished Assy | 936 | 27 | 0.8% | 87.5% |
| Polyflux | 389 | 116 | 0.3% | 79.9% |
| Unknown Distributed Dialyzer | 361 | 0 | 0% | 0.8% |
| Terumo Taf175 Hf/Cr/1 75/M | 240 | 0 | 0% | 0.8% |
| Psn Dialyzer Psn 210 | 231 | 0 | 0.8% | 76.4% |
| Clirans Taf Hf Dialyzer | 212 | 0 | 0% | 39.6% |
| Ca-Hp Dialyzer Ca-Hp 210 | 176 | 0 | 1.1% | 85.9% |
| Optiflux 200nre Dialyzer Finished Assy | 175 | 5 | 0.5% | 92% |
| Terumo | 90 | 0 | 2.8% | 12.2% |
| Fresenius | 86 | 0 | 6.1% | 13.7% |
| Dialyzer | 55 | 69 | 2.2% | 57.4% |
| Baxter | 21 | 3 | 3.8% | 54.2% |
| Optiflux F250nre Dialyzer | 15 | 0 | 0.4% | 93.8% |
| Fusa F80a Hf/Ps/1 8/H | 9 | 0 | 1.2% | 16.9% |
| Fusa F80b Hf/Ps/1 8/H | 8 | 0 | 0% | 13.7% |
| Revaclear | 2 | 19 | 1.1% | 72.8% |
| 1550 Hemodialysis Machine | 1 | 0 | 10.6% | 53.3% |
| Combi Set | 1 | 0 | 3.4% | 93.2% |
| Naturalyte | 1 | 0 | 82.2% | 0% |
| Polyflux L Capillary Dialyzer | 1 | 0 | 1.3% | 60.6% |
| Ultrafilter Hechingen | 1 | 25 | 0% | 95.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Fresenius Medical Care North America | 1,669 | 19.8% |
| Nissho | 1,186 | 14.1% |
| Baxter Healthcare | 943 | 11.2% |
| Terumo | 759 | 9% |
| Ogden Manufacturing Plant | 291 | 3.5% |
| Vantive US Healthcare | 194 | 2.3% |
| Terumo Ashitaka | 142 | 1.7% |
| Fresenius USA | 106 | 1.3% |
| Gambro Healthcare | 52 | 0.6% |
| Terumo Medical | 25 | 0.3% |
| Gambro Dialysatoren | 15 | 0.2% |
| Medcomp | 1 | 0% |
| Reynosa Manufacturing | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Fluid/blood leak | 3,000 | 35.6% |
| Leak/splashthe device leaked | 1,786 | 21.2% |
| Replace | 1,332 | 15.8% |
| Reactiona reaction, type not specified | 463 | 5.5% |
| Reuse | 356 | 4.2% |
| Device contamination with body fluid | 255 | 3% |
| Alarm, audible | 201 | 2.4% |
| Crackthe device cracked | 166 | 2% |
| Repair | 128 | 1.5% |
| Membrane leak(s) | 105 | 1.2% |
| Insufficient device problem information | 92 | 1.1% |
| Breakthe device broke | 73 | 0.9% |
| Other (for use when an appropriate device code cannot be identified) | 65 | 0.8% |
| Malfunction | 56 | 0.7% |
| Blood in tubing | 51 | 0.6% |
| Coagulation in device or device ingredient | 49 | 0.6% |
| Compatibility | 45 | 0.5% |
| Device displays incorrect message | 41 | 0.5% |
| Tears, rips, holes in device, device material | 39 | 0.5% |
| Occlusion within devicethe device blocked | 37 | 0.4% |
Questions about dialyzer, capillary, hollow fiber reports
What is product code FJI?
FDA's classification code for "Dialyzer, capillary, hollow fiber", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
8,433 reports through August 2026, 138 of them in the latest 12 months.
Which brands appear most often?
Optiflux 180nre Dialyzer Finished Assy (1,226), Ct Gamma Dialyzer Ct 190g (1,011), Optiflux 160nre Dialyzer Finished Assy (936), Polyflux (389) and Unknown Distributed Dialyzer (361). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.